There were 457 press releases posted in the last 24 hours and 222,915 in the last 365 days.


Please use this form to send email to PR contact of this press release:
Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial



Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image